UK 'increasingly confident' that vaccines work against variant from India

PM Johnson cites review of latest data on B.1.617.2; experts say spread of variants out of hotspots is key

Boris Johnson
UK PM Boris Johnson (File photo: Reuters)
Reuters London
2 min read Last Updated : May 19 2021 | 6:19 PM IST
Britain is increasingly confident that vaccines work against the coronavirus variant first found in India, Prime Minister Boris Johnson said on Wednesday, with a leading epidemiologist saying it may be spreading less quickly than at first feared.
 
Johnson has warned that the emergence of the B.1.617.2 variant might derail his plans to lift England's lockdown fully on June 21, but on Wednesday he said the latest data had been encouraging.
 
"We have increasing confidence vaccines are effective against all variants, including the Indian variant," he told parliament.
Johnson last week said the extent to which the variant could disrupt the planned exit from lockdown would depend on how much more transmissible it was.
 
Neil Ferguson, an epidemiologist at Imperial College London, said there was a "glimmer of hope" from the latest data that the transmissibility of the variant might be lower than first feared.
 
"The magnitude of that advantage seems to have dropped a little bit with the most recent data," he told BBC radio, adding more data was needed.
 
He said that while there was a "good deal of confidence" that vaccines would continue to protect against severe disease, the variant might lead to reduced vaccine efficacy against infection and transmission.
 
Ferguson said the initial rapid growth of B.1.617.2 had been among people who had travelled and who had a higher chance of living in multi-generational households or in deprived areas, and the ease of transmission might not be replicated in other settings.
Graham Medley, a professor of disease modelling at the London School of Hygiene and Tropical Medicine and a member of the government's Scientific Advisory Group for Emergencies (SAGE), said that while the variant was growing quickly in some places, "we haven't yet seen it take off and grow rapidly everywhere else".
 
"One of the key things we'll be looking for in the coming weeks will be: how far does it spread outside of those areas," he told Reuters.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :CoronavirusCoronavirus VaccineCoronavirus Tests

Next Story